NanoViricides Inc. (NNVC)

[arvitar]

Easy (for you) question:

On p.47 of NNVC's recent 10-Q they say this:
https://www.sec.gov/Archives/edgar/data/1379006/000114420418030083/tv492966_10q.htm


"The Company had cash and cash equivalents of approximately $10,618,000 as of March 31, 2018 and accounts payable and accrued liabilities of approximately $602,000. In addition, the Company had account payables due to a related party, TheraCour Pharma, Inc. of approximately $1,689,000."



Why did they write it up in this way? What I mean is, are current liabilities not subtracted from cash and cash equivalents?

Either way, why specifically mention the $602K and the $1,689K here at all? Or put another way, why these bits of information and not others from their balance sheet?